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Abstract
Purpose The incidence of oral squamous cell carcinomas
(OSCC) arising around dental implants will increase
because of the rising popularity of dental implants. In this
case, a novel surgical treatment of an OSCC in the vicinity
of endosseous implants is reported.
Materials and methods In a 69-year-old woman, a recurrent
OSCC (cT2N0M0) developed in the floor of the mouth
extending to the attached keratinized peri-implant mucosa of
both interforaminal-placed dental implants. Radiographically,
no bone invasion could be observed.
Results To radically remove the tumor, a marginal
mandibulectomy was performed including the cranial parts
of both dental implants by cutting them into two parts.
Three years after tumor resection and one year after
reimplantation, the patient is disease free and has a good
oral function.
Conclusions In case of an OSCC, traditional bone and soft
margins for oncologic safety are 1.0 cm. If a dental implant
is present within this safety zone, on condition, there is no
massive bone invasion, and the original mandible has
sufficient vertical height; a marginal mandibulectomy




In view of the gaining popularity of oral endosseous
implants in general and specifically the extended use of
implants in patients with head and neck cancer to give
retention to a (partial) dental prosthesis, the issue of
malignancies arising in the vicinity of dental implants will
be encountered in the future more often [1, 2]. Primary oral
squamous cell carcinomas (OSCC), recurrences, or even
second primary tumors may arise in the vicinity of already-
functioning implants. Few reports have been published
about this issue [3–13]. Sometimes, their initial clinical
appearance suggested peri-implantitis [4, 7, 13], thereby
demonstrating that malignancies can masquerade as a
benign peri-implant complication. It has to be emphasized
that a high degree of vigilance is required. The majority of
all presented cases had at least one recognized risk factor
for oral cancer [6], thereby stressing that the carcinogenic
role of endosseous implants has never been established [1].
Surgery with postoperative radiotherapy on indication is
still the first choice of curative treatment for an OSCC.
Surprisingly, in the literature, the topic of the type of
resection when dental implants are adjacent or around the
tumor is only limitedly addressed. When no evident bone
invasion is present, a simple technique of removing the
tumor including the dental implants can be used.
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A 65-year-old female, suffering from an OSCC of the right
anterior floor of the mouth (pT1N2bM0), was treated in
November 2002 with a wide excision in combination with a
lateral neck dissection at the right side. To achieve radical
removal, the lower teeth had to be extracted, and the alveolar
process was reduced in height. Subsequently, two endosseous
implants (TiUnite Mark III RP, Nobel Biocare®, Gothenburg,
Sweden) were placed into the symphyseal region of the
mandible to facilitate early prosthetic rehabilitation [1, 2].
Postoperatively, the patient was subjected to a fractionated
radiotherapy schedule up to a cumulative dose of 64 Gy (32
times, receiving 2 Gy at each session) because of a spidery
growth pattern and two ipsilateral positive lymph nodes of
level Ib. After a healing period of 3 months postradiation, the
patient desired prosthetic rehabilitation. Consecutively,
healing abutments were placed (June 2002), and a bar-
retainedoverdenture was fabricated. Since then, this construc-
tion functioned satisfactorily for about 4 years without further
complications.
Unfortunately, in October 2006, 4 years postradiation, a
recurrent OSCC (cT2N0M0) developed. Between the two
implants, an exophytic tumor was observed in the floor of
the mouth extending to the attached keratinized peri-implant
mucosa of both implants (Fig. 1a). Radiographically (OPG
and CTscan), no osteolytic lesions around the dental implants,
indicative for bone invasion, could be observed [14].
To achieve radical removal, first, a tumor-free mucosal
margin of 1 cm was outlined. Subsequently, the mandibular
bone surface was exposed by careful elevation of the
mucoperiosteum in caudal direction, thereby preserving the
attachmentofthesofttissuetotheaimedcranialbonesegment
(Fig. 1b). Then, the marginal mandibulectomy was per-
formed, utilizing a standard drill unit (Elan-EC, Aesculap®,
Tuttlingen, Germany) connected to a saw using a standard
saw blade (Braun-Aesculap® sterile blades, Ref GC615R;
Tuttlingen, Germany). During the osteotomy, consecutively,
the implants were also cut into two parts (Fig. 1c, d).
Postoperatively, the lower denture was not worn for
6 months. The mucosal defect was closed primarily. In
addition, the patient was warned of the risk of fracture and
instructed about oral hygiene and soft diet. The soft tissues
healed well (Fig. 2).
Histology showed a radically removed tumor with an
8-mm free mucosal margin. The tumor had an infiltrative
spidery-typegrowthpatterninthelaminapropria.Fortunately,
no bone, perineural, or intravascular invasion was observed.
Two years postoperatively (November 2008), it was
decided to insert dental implants again. After exposing the
mucoperiostal flap, the apical parts of the cut implants could
be easily identified (Fig. 3). Three years after resection of the
recurrent tumor and 1 year after reimplantation, the patient is
disease free and has a good oral function.
Discussion
Only few previously reported cases of malignancies arising
in the vicinity of dental implants have been published
[3–13]. Definitely, this number will increase in the future
due to two main reasons. Firstly, prosthetic rehabilitation
Fig. 1 a The carcinoma is
positioned between the white
arrows. b First, an incision is
made, respecting a border (see
arrows) of 1 cm around the
tumor. c Intraoral view after
removing the upper bone
segment. Clearly, the apical
parts of both implants are
visible, as also d the cervical
parts in the block resection
(see arrows)
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cating that, within the group developing an OSCC, more
patients will show up with endosseous implants. Secondly,
in patients suffering from intraoral carcinomas, there is
more and more tendency to install endosseous implants to
restore their oral functioning [1, 2]. The fact that tumor
recurrences appear mainly in the first two postoperative
years explains why the phenomenon of a “tumor around
endosseous implants” will occur significantly more in the
coming years.
Some authors discuss the topic of peri-implant carcinomas
first presenting itself as peri-implantitis. They emphasize that,
in patients with long-standing and recurring leukoplakia,
heavy smoking, and alcohol abuse, a biopsy should be taken
[4, 7, 13]. Obviously, if the patient already has a history of
malignancy, each oral lesion, including peri-implantitis, is a
suspect for carcinoma.
A literature search yielded 11 previously documented
cases of malignancy adjacent to implants [3–13]. No papers
emphasize that osseointegrated implants have been clearly
identified as a potential route of entry for OSCC into the
mandible. However, one report illustrated an OSCC that
occurred in relation to osseointegrated implants, showing
the apparent invasion of the mandibular alveolus by tumor
along the line of the implant fixture [12].
To our knowledge, this is the first report that describes
the removal of implants in the vicinity of an OSCC by
cutting them consecutively during the marginal mandib-
ulectomy. To remove an osseointegrated implant, alterna-
tively, with round or hollow cylinder burrs, a gap could be
prepared around the implant. From an oncological point of
view, this approach is undesired with respect to tumor spill/
spread. Moreover, removing an implant in total creates a
gap in the mandibular bone, increasing significantly the risk
of mandibular fractures. In case of a total mandibulectomy,
an extensive reconstruction of the anterior mandible would
be mandatory. Surprisingly, this sawing procedure was
much easier than expected, thereby leaving the apical parts
in the lower mandibular bone segment (Fig. 1d). The
residual vertical mandibular height was 11 mm. It should be
Fig. 3 a Situation after placement of three implants. The cut implants
(white arrows) can be easily identified. b Panoramic radiograph
postoperatively showing both the new and the cut implants (white
arrows)
Fig. 2 a Panoramic radiograph
preoperatively showing both
the implants with their
interconnecting bar and b after
resection. Notice the round
edges of the osteotomy (white
arrows). c Intraoral view 1 year
after partial implant removal
Oral Maxillofac Surg (2010) 14:253–256 255emphasized that sharp edges between the horizontal and
vertical bone cuts have to be avoided, as these may lead to
fractures [15].
In case of an OSCC, traditional bone and soft margins
for oncologic safety are 1.0 cm. In the anterior mandible, a
marginal mandibulectomy is only indicated when there is
sufficient height of the inferior border present. To limit the
risk of pathologic fracture, at least a residual vertical bone
height of 10 mm should be left. This method allows radical
removal of the tumor, without the direct need of performing
a more invasive segmental mandibulectomy. However, if
radiographically bone resorption around the implants is
observed, indicative for tumor invasion, a more radical
surgical approach (e.g., segmental resection) is indicated.
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